Digitoxin
Back to searchMolecule Structure
Scientific Name
Digitoxin
Description of the Drug
Digitoxin is a cardiac glycoside used in the treatment and management of congestive cardiac insufficiency, arrhythmias and heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01396
http://www.drugbank.ca/drugs/DB01396
Brand Name(s)
Crystodigin, Digimerck, Nativelle digitaline
Company Owner(s)
Eli Lilly And Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium/potassium-transporting ATPase | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095186 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL20940 | |
PharmGKB | PA449316 | |
Human Metabolome Database | HMDB0015468 | |
DrugBank | DB01396 | |
PubChem: Thomson Pharma | 14889043 | 16335905 |
PubChem | 441207 | |
Mcule | MCULE-8291336831 | MCULE-9783596421 |
NMRShiftDB | 60064368 | |
Nikkaji | J8.586C | |
PDBe | F9R | |
BindingDB | 46356 | |
EPA CompTox Dashboard | DTXSID0022933 | |
LipidMaps | LMST01120018 | |
DrugCentral | 881 | |
Brenda | 13679 | |
ChemicalBook | CB5194029 | |
Guide to Pharmacology | 6782 | |
rxnorm | DIGITOXIN | |
PubChem: Drugs of the Future | 12015761 | |
KEGG Ligand | C06955 | |
ChEBI | 28544 | |
ZINC | ZINC000095862733 |